Regenerating islet-derived 3-alpha is a biomarker of gastrointestinal graft-versus-host disease

Control of epithelial cell function by interleukin-22-producing RORγt+ innate lymphoid cells

(2011) Stephanie L. Sanos et al.   IMMUNOLOGY

The Wnt agonist R-spondin1 regulates systemic graft-versus-host disease by protecting intestinal stem cells

(2011) Shuichiro Takashima et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Graft-versus-Host Disease Treatment: Predictors of Survival

(2010) John E. Levine et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The best endpoint for acute GVHD treatment trials

(2010) M. L. MacMillan et al.   BLOOD

Pathology of graft-versus-host disease in the gastrointestinal tract

(2009) Kay Washington et al.   HUMAN PATHOLOGY

Graft-versus-host disease

(2009) James LM Ferrara et al.   LANCET

A biomarker panel for acute graft-versus-host disease

(2008) S. Paczesny et al.   BLOOD

Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens

(2008) Yan Zheng et al.   NATURE MEDICINE